In contrast, co-administration of Trolox + Aβ1 − 42 significantly reduced the immunoreactivity of GFAP and Iba1 in the cortex and hippocampus regions in AD-induced mice (Figure 4B). This evidence concerns the gene GFAP and Alzheimer disease.